SCHEMBL19822671

SCHEMBL19822671

CCCCCc1ccc(-c2ccc(-c3ccc(C(Cl)(Cl)Cl)cc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 6/20 0.53
▸ HSD17B10 Q99714 3/20 0.53
▸ TSHR P16473 1/20 0.53
▸ HRH3 Q9Y5N1 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ RARA P10276 1/20 0.51
▸ MTOR P42345 1/20 0.51
▸ KDM4E B2RXH2 3/20 0.48
▸ ESR1 P03372 2/20 0.48
▸ ADRA2A P08913 2/20 0.48
▸ ADORA3 P0DMS8 2/20 0.48
▸ TACR2 P21452 2/20 0.48
▸ SLC6A2 P23975 2/20 0.48
▸ SLC6A4 P31645 2/20 0.48
▸ SLC6A3 Q01959 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ SHBG P04278 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11469646 0.92 ESR1 (0.57) HSD17B10ALDH1A1KDM4EESR1ADRA2A
SCHEMBL8089720 0.88 CA2 (0.48) RARBHSD17B10ALDH1A1KDM4EESR1
SCHEMBL10379965 0.84 RARB (0.68) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL31549867 0.84 RARB (0.68) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL11657350 0.82 HSD17B10 (0.71) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL11660215 0.82 HSD17B10 (0.71) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL11664281 0.82 HSD17B10 (0.71) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL11661972 0.82 HSD17B10 (0.71) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL17108417 0.81 MAOB (0.58) RARBHSD17B10TSHRHRH3ALDH1A1
SCHEMBL10382748 0.81 MAOB (0.58) RARBHSD17B10TSHRHRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180030353-A1 REACTIVE PERPENDICULAR ALIGNED ORGANOSILICON MATERIAL AND MANUFACTURE METHOD OF LIQUID CRYSTAL DISPLAY PANEL SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2018-02-01 — — US disclosed
US-20180030353-A1 REACTIVE PERPENDICULAR ALIGNED ORGANOSILICON MATERIAL AND MANUFACTURE METHOD OF LIQUID CRYSTAL DISPLAY PANEL SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2018-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030353-A1 REACTIVE PERPENDICULAR ALIGNED ORGANOSILICON MATERIAL AND MANUFACTURE METHOD OF LIQUID CRYSTAL DISPLAY PANEL VCL, C1S, CFH RARB 4357/4885HSD17B10 1159/4885TSHR 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback